

I’m not convinced it’s efficiency driving the difference.
China have the advantage of lower labour and production costs (although that will change as their economy matures).
Regardless, pharma costs are heavily driven by R&D, risk, and regulation. A huge amount of R&D goes into products that never make it to market, which is a necessary investment. Most (all?) western pharma companies operating in the US have had massive Tort settlements, and their prices have to include a margin to finance that risk (insurance is expensive, if it’s even available). Then there’s regulation. The US and Europe very heavily regulate these companies. I’d be interested to know how the Chinese regulations compare, especially for Chinese headquartered companies.
Finally, China should be doing more clinical trials than the US + EU combined given the size of their population, so it’s great that they’re finally developed enough.
I see their growing competitiveness as a natural consequence of their developing economy and not due to any failure in the West.
I can’t believe I just wasted time reading this.
Tldr: GOS accused OP of trying to create public drama and instead of taking multiple opportunities to deescalate, OP kept pushing and got banned.
So, if GOS was wrong about OP wanting to create public drama, then why have they made this post?
I’m not saying GOS didn’t overreact but that whole conversation was at the level of 13 year olds. Surely, OP, you can do better?
Specifically:
If all you wanted was to share the information with CalyxOS, wouldn’t the logical option have been to copy the relevant text from @jertek’s comment (which you had already recovered), and quote it in a comment on your CalyxOS feature request? You could have linked to @jertek there and continued the conversation without involving GOS.
You know GOS aren’t intending to implement this feature - you were informed of that on the GOS discussion forum before opening the ticket. (I just searched the forum for this topic because I was so sure I must be missing context but no, not really.) So when they deleted the request, why not let it go? I just don’t get why it mattered so desperately that they deleted your feature request, and why you couldn’t clarify that anywhere except on a clone of their repo. I really, genuinely don’t.